We are live on ! Find out more
KURA icon

Kura Oncology
KURA

127 hedge funds and large institutions have $537M invested in Kura Oncology in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

53% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 32

49% more call options, than puts

Call options by funds: $233K | Put options by funds: $156K

9% more funds holding

Funds holding: 116 → 127 (+11)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2.83% less ownership

Funds ownership: 88.99% → 86.16% (-2.8%)

12% less capital invested

Capital invested by funds: $610M → $537M (-$73.4M)

Holders
127
Holders Change
+11
Holders Change %
+9.48%
% of All Funds
2.5%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
24
Increased
49
Reduced
32
Closed
7
Calls
$233K
Puts
$156K
Net Calls
+$77K
Net Calls Change
+$55K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.33M
2
Goldman Sachs
Goldman Sachs
New York
+$6.48M
3
EC
EcoR1 Capital
California
+$2.96M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.37M
5
AG
Artal Group
Luxembourg
+$2.22M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$33.1M
2
AVM
Arch Venture Management
Illinois
-$7.41M
3
DCM
Driehaus Capital Management
Illinois
-$6.31M
4
CAM
Cormorant Asset Management
Massachusetts
-$3.43M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$2.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPCM
76
Pillar Pacific Capital Management
California
$357K – – –
Federated Hermes
77
Federated Hermes
Pennsylvania
$346K -$2.88M -194,362 -89%
UBS AM
78
UBS AM
Illinois
$327K +$1.79K +121 +0.5%
HF
79
HRT Financial
New York
$308K +$332K +22,436 New
CC
80
Caxton Corporation
New Jersey
$307K -$137K -9,272 -29%
Rafferty Asset Management
81
Rafferty Asset Management
New York
$296K -$568K -38,307 -64%
AIG
82
American International Group
New York
$295K -$2.68K -181 -0.8%
Qube Research & Technologies (QRT)
83
Qube Research & Technologies (QRT)
United Kingdom
$293K +$316K +21,297 New
Manulife (Manufacturers Life Insurance)
84
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$292K +$682 +46 +0.2%
AC
85
Athanor Capital
New York
$283K -$129K -8,693 -30%
Jacobs Levy Equity Management
86
Jacobs Levy Equity Management
New Jersey
$265K -$2.96K -200 -1%
RJA
87
Raymond James & Associates
Florida
$253K -$3.5K -236 -1%
SIM
88
Spark Investment Management
New York
$246K -$185K -12,478 -41%
Truist Financial
89
Truist Financial
North Carolina
$227K +$244K +16,463 New
JG
90
Jefferies Group
New York
$226K +$243K +16,414 New
VOYA Investment Management
91
VOYA Investment Management
Georgia
$223K +$60.2K +4,063 +33%
CSS
92
Cubist Systematic Strategies
Connecticut
$216K +$232K +15,684 New
ProShare Advisors
93
ProShare Advisors
Maryland
$199K -$25.1K -1,696 -11%
MIM
94
MetLife Investment Management
New Jersey
$188K – – –
Ensign Peak Advisors
95
Ensign Peak Advisors
Utah
$183K +$197K +13,294 New
Citigroup
96
Citigroup
New York
$177K -$381K -25,681 -67%
AIM
97
Aigen Investment Management
New York
$174K +$187K +12,634 New
TI
98
Trexquant Investment
Connecticut
$169K +$182K +12,261 New
TRCT
99
Tower Research Capital (TRC)
New York
$166K +$134K +9,066 +305%
Los Angeles Capital Management
100
Los Angeles Capital Management
California
$154K -$2.22K -150 -1%
2 3
4
5 6

KURA Hedge Fund Activity: Q4 2019 in Review

127 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2019, worth a combined $537M — down 12% from $610M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KURA positions and 7 closed out — a net gain of 17 holders — while 49 added to existing stakes and 32 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $9.33M. The largest seller was Great Point Partners, cutting an estimated $33.1M.

  • 127 institutional investors held Kura Oncology (KURA) as of Q4 2019, up from 116 in Q3 2019.
  • Funds reported $537M of Kura Oncology stock for Q4 2019, down 12% quarter-over-quarter.
  • 24 funds opened new Kura Oncology positions in Q4 2019 and 7 closed out, a net change of +17 holders.
  • The largest Kura Oncology buyer in Q4 2019 was Millennium Management, an estimated $9.33M added.
  • The largest Kura Oncology seller in Q4 2019 was Great Point Partners, an estimated $33.1M sold.

Based on aggregated 13F filings for Q4 2019.